What happens at a Fitness to Practise Committee hearing
If your case is referred to the Fitness to Practise Committee, it will be heard by an independent panel. The GPhC will be represented by a presenting officer. You have the right to be legally represented and we strongly advise that you are. The panel will consider whether the facts are proved, whether those facts amount to impaired fitness to practise, and what sanction if any is appropriate. Sanctions available to the panel include a warning, conditions of practice, suspension, and removal from the register. The panel can also impose no sanction if it concludes the case does not warrant one. Hearings are usually held in public. The process is formal and adversarial. The presenting officer will have reviewed the case thoroughly and will test your account. Unrepresented registrants are at a significant disadvantage.
The self-declaration obligation
If you become aware of any matter that may affect your fitness to practise, you are required to tell the GPhC promptly. This includes criminal investigations, police cautions, convictions, and matters arising in other regulatory proceedings. The obligation applies even where you are not yet sure whether the matter is relevant. If you are in any doubt about whether something triggers your self-declaration obligation, take advice before the window for voluntary disclosure closes. Late or incomplete disclosure can aggravate your position in any subsequent investigation.
Receiving a letter from the General Pharmaceutical Council is an unsettling experience for any pharmacist or pharmacy technician. Your registration is your livelihood, and a concern raised with the GPhC can feel like a threat to everything you have worked for. Before you respond, speak to colleagues, or write anything down, it is worth understanding what the process actually involves and what the critical early decisions are.
What the letter means, and what it does not
A letter from the GPhC at this stage usually means that a concern has been raised about you, and that the GPhC is assessing whether it needs to investigate. The concern may have come from a patient, a colleague, your employer, a coroner, or another regulator. It may also have been triggered by something you have declared yourself.
The GPhC only investigates concerns where patient safety could be at risk or public confidence in pharmacy could be affected. Not every concern leads to a full investigation. The GPhC will check whether the concern falls within its remit and whether it is serious enough to take further. Many concerns are closed at this initial stage without any further action.
Receiving the letter does not mean you have been found to have done anything wrong. It means a concern exists, and the GPhC is looking at it.
Your duty to self-report
One feature of the GPhC’s process that makes it distinct from most other regulators is the self-reporting obligation. As a pharmacist or pharmacy technician, you are required to tell the GPhC within seven days if you become aware of an issue that may affect your fitness to practise. This includes police cautions, criminal investigations, and investigations into professional wrongdoing. If you are unsure whether something triggers this obligation, take advice before the seven days expires rather than after.
How the investigation works
If the GPhC decides to investigate, the case will usually be led by a case officer. The investigation can include speaking to the person who raised the concern and any witnesses, speaking to you as the pharmacy professional involved, working with GPhC inspectors, and in some cases visiting the pharmacy premises where an alleged incident took place.
You will be invited to respond. The GPhC will update you on progress every two months throughout the investigation. Investigations can take between four and twelve months from the point the concern was first raised, depending on the complexity of the case.
What you should do first
Do not respond to the GPhC letter without taking advice. Your response becomes part of the case record. A poorly worded or reactive response can complicate your position significantly. Before you put anything in writing, speak to a specialist regulatory solicitor.
Do preserve everything. Do not delete messages, alter records, or destroy documents. If it emerges that anything relevant has been withheld or destroyed, that will aggravate your position considerably.
Do check whether your employer’s indemnity arrangements cover regulatory defence, and whether your professional indemnity insurance provides any cover for legal representation during an investigation. Check early and, if cover exists, notify the relevant party promptly.
Do consider the impact on your employer. In a pharmacy context, your employer may receive contact from the GPhC as part of the investigation. Being open with your employer about the situation, on advice, is generally better than them finding out through the GPhC.
The two-committee structure
If the investigation concludes that there is a case to answer, it will be considered by one of two committees. Understanding this structure matters because it shapes how the process unfolds.
The Investigating Committee meets in private. It considers the case and applies what the GPhC calls the real prospect test, asking whether there is a real possibility that the facts could be proved by the Fitness to Practise Committee. If the Investigating Committee decides there is a case to answer, it can refer the matter to the Fitness to Practise Committee. It can also issue advice or a warning, put undertakings in place with you, or close the case. In serious or urgent cases, the GPhC can bypass the Investigating Committee and refer directly to the Fitness to Practise Committee.
The Fitness to Practise Committee usually holds hearings in public. At a hearing, the GPhC must prove the facts alleged against you on the balance of probabilities. If the committee finds your fitness to practise impaired, it can issue advice or a warning, impose conditions on your practice, suspend you from the register, or remove you from the register altogether.
What can happen at the end of the process
The range of outcomes is broad. At one end, the GPhC may take no further action after the initial assessment or investigation. It may send guidance on how you should practise in future, or enter into a voluntary monitoring agreement if health is a factor. At the other end, following a Fitness to Practise Committee hearing, sanctions can include conditions, suspension, or removal from the register.
A referral to a committee does not mean removal is inevitable. Many cases result in conditions, undertakings, or a warning. The outcome depends on the nature and seriousness of the allegations, your response to the process, the evidence, and how your case is presented.
Why the first response matters
The GPhC takes into account how a pharmacy professional has engaged with its process. Early, well-advised engagement that demonstrates insight, remediation, and a commitment to patient safety can make a real difference to the outcome. An unadvised, reactive response can foreclose options and create problems that are difficult to undo.
Regulated by a different body?
We act for regulated professionals across all major UK bodies. If your regulator is different, we have guides for
NMC-registered nurses, midwives and nursing associates,
GMC-registered doctors,
SRA-regulated solicitors, and
HCPC registrants. For full detail on how we defend GPhC fitness to practise investigations and hearings, visit our
GPhC fitness to practise service page.
Regulatory Defence acts for pharmacists and pharmacy technicians facing GPhC investigations and fitness to practise proceedings. If you have received a letter from the GPhC, contact us for a free initial telephone consultation. We will explain the process clearly and tell you honestly how we can help.